CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13 enrolled
Drug / intervention
CGMS Device +1 moredevice
Likely dose
Not stated in record
Key inclusion· 3
  • ✓Type 1 diabetes diagnosis
  • ✓HbA1c ≥8% (poorly controlled)
  • ✓Naive to continuous glucose monitoring system use
Key exclusion· 3
  • ✕Developmental delay
  • ✕Does not regularly test blood glucose with a meter at home
  • ✕No access to a telephone

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03020069
NCT03020069N/ACompleted
CompareCT.gov

Use of Continuous Glucose Monitoring System With Intensive Feedback in Adolescents With Poorly Controlled Type 1 Diabetes

NYU Langone Health·interventional·Posted Jan 13, 2017·Updated Mar 16, 2020

In Brief

A clinical study evaluating CGMS Device and No Device for Type 1 Diabetes. Completed, enrolled 13 participants across 1 site.

Detailed Summary

The purpose of this study is to determine that continuous glucose monitoring systems (CGMS) with intensive real time feedback about diabetes management from medical staff to the patient will affect motivation and/or behavior, in adolescents with poorly controlled type 1 diabetes. The investigators hypothesize that short-term CGMS use with feedback (and/or lack thereof) and patients' sense of self-efficacy will influence their stage of change and potentially glucose levels.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 13, 2017
Enrollment StartNov 1, 2015
Primary CompletionJul 13, 2018
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 9.5 years ago

Interventions

CGMS Devicedevice

No Deviceother